Sutro Biopharma, Inc. (STRO)
12.31
+0.56
(+4.77%)
USD |
NASDAQ |
Jan 09, 16:00
12.31
0.00 (0.00%)
After-Hours: 17:37
Sutro Biopharma EPS Diluted (Quarterly): -6.699 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| GT Biopharma, Inc. | -0.8268 |
| Daré Bioscience, Inc. | -0.2793 |
| Syndax Pharmaceuticals, Inc. | -0.7009 |
| Crinetics Pharmaceuticals, Inc. | -1.381 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -56.86M |
| Revenue (Quarterly) | 9.693M |
| Total Expenses (Quarterly) | 66.55M |
| Enterprise Value | 160.05M |
| Gross Profit Margin (Quarterly) | 80.40% |
| Profit Margin (Quarterly) | -586.6% |
| Earnings Yield | -144.2% |
| Normalized Earnings Yield | -123.97 |